WY TRI Pointe Homes beats top, bottom line and raises

New Post Public Reply Private Reply Replies (0) Message Board
MiamiGent
WY TRI Pointe Homes beats top, bottom line and raises guidance. (TRI will be merging with Weyerhaeuser ( WY ) in the first half of 2014).
Weyerhaeuser also beat top, bottom line in its late October Earnings Report.
WY PPS found support last few days at RSI 40 and MACD centerline, printing reversing hammer candlestick at price support and rising 50 SMA.

http://stockcharts.com/h-sc/ui?s=WY



TRI Pointe Homes, Inc. Reports 2013 Third Quarter Results
BY Business Wire — 6:00 AM ET 11/13/2013
IRVINE, Calif.--(BUSINESS WIRE)-- TRI Pointe Homes, Inc. today announced record results for the third quarter ended September 30, 2013.

2013 Third Quarter Highlights and Comparisons to the 2012 Third Quarter

Net income was $4.7 million, or $0.15 per diluted share compared to a net loss of $(1.5) million, or $(0.10) per diluted share
New home orders increased to 135 compared to 74...

Cash, cash equivalents and marketable securities were $62.2 million compared to $19.8 million as of December 31, 2012
Ratio of debt to capital improved to 22.8% compared to 27.8% as of December 31, 2012
Douglas F. Bauer, Chief Executive Officer stated, “Our team continued to execute on our plan ......we are raising our full year 2013 guidance.”

“With our recent announcement of an agreement to acquire Weyerhaeuser Real Estate Company (“WRECO”), we have accelerated our long term plan to be a leading regional homebuilder in some of the nation’s fastest growing markets,” Mr. Bauer continued. The combination of WRECO’s’ local market knowledge and TRI Pointe’s strong and established history of success should result in a powerful and focused homebuilding company. This transformative transaction will enable us to broaden our geographic presence, expand our California land holdings, enhance our operating teams with deep talent at all levels of the organization, providing us with the ability to drive future earnings and growth. Furthermore, our market capitalization should expand in excess of $2.5 billion, providing additional liquidity and financial flexibility for the company and our stockholders.”

Third quarter 2013 operating results

Net income was $4.7 million, or $0.15 per diluted share in the third quarter of 2013, compared to a net loss of $(1.5) million, or $(0.10) per diluted share for the third quarter of 2012, primarily driven by a $11.9 million increase in homebuilding gross margin due to higher home sales revenue and increased homebuilding gross margin percentages, offset by an increase in SG&A expense of $3.6 million and an increase in our provision for income taxes of $1.8 million. Net income for the third quarter of 2013 was positively impacted by $906,000 in tax benefit recorded to the Company’s provision for income taxes related to the reversal of the valuation allowance on the Company’s deferred tax assets. The valuation allowance was reversed as a result of, among other things, the Company’s recent financial and operating results including three years of cumulative income, four consecutive quarters of profitability and strong growth in orders and backlog. Net income for the third quarter of 2013 impacted by $(490,000) related to costs associated with the WRECO transaction.

Home sales revenue increased $46.8 million to $56.8 million for the 2013 third quarter, as compared to $10.0 million for the same period in 2012, primarily attributable to a significant increase in new homes delivered to 91 and a growth in the Company's average sales price of homes delivered to $624,000.......

New home orders increased to 135 homes for the 2013 third quarter, the highest amount of quarterly orders since the Company began acquiring land in 2010......

The Company’s homebuilding gross margin percentage for the 2013 third quarter increased to 23.0% compared to 11.7% for the same period in 2012.....

------------------------------

Weyerhaeuser (WY) beats estimates as homebuilding business improves
BY Reuters — 7:08 AM ET 10/25/2013
Oct 25 (Reuters) - Timber conglomerate Weyerhaeuser Co (WY)reported a better-than-expected quarterly profit as margins improved in its homebuilding business, which it is looking to sell.

The company is in advanced talks to sell its homebuilding and real estate development unit for $2.7 billion to Tri Pointe Homes Inc, Reuters reported earlier this week, quoting sources familiar with the matter.

Weyerhaeuser, which said in June it was reviewing strategic options for the unit, said on Friday it expects "significantly" higher earnings from single-family homebuilding this quarter.

Closings for single-family homes are expected to increase to over 1,100 in the fourth quarter from 768 in the third quarter, the company said on Friday.

Weyerhaeuser said it expects higher average closing prices and selling-related costs at the business due to the additional closing volumes.

The business accounted for a fifth of the company's net profit in the third quarter.

The homebuilding industry in the United States is adjusting to a slowdown in new orders after seven consecutive quarters of strong demand as rising interest rates and economic uncertainty deter buyers.

The Dow Jones Home Construction index has lost a fifth of its value since May.

Weyerhaeuser's third-quarter net earnings rose to $157 million, or 27 cents per share, from $117 million, or 22 cents per share, a year earlier.

Net sales jumped 23 percent to $2.18 billion.

Analysts expected a profit of 21 cents per share on revenue of $2.09 billion, according to Thomson Reuters I/B/E/S.

PulteGroup Inc, the No. 2 U.S. homebuilder, reported higher third-quarter gross margins on Thursday, and said a slowdown in new home orders would be "short-lived" as Americans return to the market after a period of economic uncertainty. (Reporting by Sayantani Ghosh in Bangalore; Editing by Saumyadeb Chakrabarty) 

Weyerhaeuser Company (WY) Stock Research Links

WY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 19

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 180

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Tony Perkins' Church Tour amid Controversial Vote

Updated Category News Views 89

Lining the pews in Missouri and Kansas, folks are about to get a powerful dose of Tony Perkins this weekend. The Family Research Council President is driving straight into the heart of both spiritual and political fervor at a couple of church stops on Sunday, October 25—right on the doorstep of a crucial vote in Missouri. Taking the Stage in a Time of Tension Now,...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 85

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 67

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
NEXT Properties Exchange Offers: The Full Breakdown

Updated Category News Views 103

What's the Deal with These Exchange Offers? You know, nothing says 'we're changing things up' like an exchange offer. So what did NEXT Properties do? Well, they laid down two offers for the books on their outstanding 6.950% and 6.390% senior notes, due in 2044 and 2050, respectively. These are getting swapped out for some fresh 7.731% senior sustainability-linked notes...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 95

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
CASEKOO's Spooky Collectibles: Postcards Meet Cases

Updated Category News Views 77

Here we go with an unexpected twist in the phone accessory game. CASEKOO decided it's time to mix things up this Halloween with something as peculiar as it is intriguing: limited-edition Spooky Season Commemorative Postcards. A Spooky Strategy to Celebrate Ten Years Get this, folks—CASEKOO's looking to mark a decade in the business with more than just confetti and a...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 150

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading

Top 5 Most Recently Viewed Articles

Emerging Trends in the Quantum Key Distribution Sector

Updated Category News Views 357

Overview of Quantum Key Distribution Growth The global Quantum Key Distribution (QKD) market is poised for significant growth. Analysts anticipate that the market will expand from USD 0.48 billion in 2024 to USD 2.63 billion by 2030, representing a remarkable Compound Annual Growth Rate (CAGR) of 32.6%. This forecast underscores the urgency for organizations to bolster...

Continue Reading
Understanding the Growing Cloud Endpoint Protection Market

Updated Category News Views 170

In 2023, the cloud endpoint protection market stood at about USD 5.1 billion, but oh boy, was that just the start of a massive wave. Fast forward to projections for 2033, and we’re talking around USD 23.6 billion—a staggering compound annual growth rate (CAGR) of roughly 22.7%. What does this tell us? The need for robust endpoint protection ain't slowing down anytime...

Continue Reading
Hartford HealthCare Cancer Institute Achieves MSK Care Partner Status

Updated Category News Views 129

Historic Milestone in Cancer Care Hartford HealthCare Cancer Institute has made a remarkable achievement by becoming the first healthcare system in the United States to be designated as a Care Partner of Memorial Sloan Kettering Cancer Center (MSK). This prestigious recognition highlights Hartford HealthCare's commitment to providing exceptional oncology care and elevates...

Continue Reading
Actinogen Advances with New Drug Name for Alzheimer's Treatment

Updated Category News Views 330

Actinogen Medical Introduces Emestedastat for Xanamem Actinogen Medical Limited (ASX: ACW) has announced a significant milestone in its Alzheimer's treatment journey with the introduction of the nonproprietary name 'emestedastat' for its leading drug, Xanamem. This recognition by the World Health Organization (WHO) places Actinogen at the forefront of clinical innovation...

Continue Reading
Gilead Sciences Insider Moves Spark Investor Interest

Updated Category News Views 146

Insider Activity at Gilead Sciences: Key Updates Recently, a significant transaction was reported by Jeffrey Bluestone, a Board Member at Gilead Sciences (NASDAQ: GILD). In a filing with the SEC, it was revealed that Bluestone exercised stock options for a total of 5,000 shares. This transaction was valued at $296,250, drawing important attention from investors and market...

Continue Reading